Log in

Relevant bibliographies by topics / Metastatic cancer / Books

Books on the topic 'Metastatic cancer'

To see the other types of publications on this topic, follow the link: Metastatic cancer.

Author: Grafiati

Published: 4 June 2021

Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Metastatic cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Swanton, Charles, and Stephen R. D. Johnston. Handbook of metastatic breast cancer. 2nd ed. New York: Informa Healthcare, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Sherbet, G. V. The Metastatic Spread of Cancer. London: Palgrave Macmillan UK, 1987. http://dx.doi.org/10.1007/978-1-349-09577-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kaufmann, M. Therapeutic management of metastatic breast cancer. Berlin: Walter de Gruyter & Co, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Leong, Stanley P. L., ed. From Local Invasion to Metastatic Cancer. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-087-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Metastatic cancer: Clinical and biological perspectives. Austin, Texas, USA: Landes Bioscience, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

1952-, Wick Mark R., ed. Metastatic carcinomas of unknown origin. New York: DEMOS, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Chu, Edward. New treatment strategies for metastatic colorectal cancer. [Manhasset, NY]: CMP Medica, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

New treatment paradigms in metastatic breast cancer. [Manhasset, NY]: CMPMedica, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Chu, Edward. New treatment strategies for metastatic colorectal cancer. [Manhasset, NY]: CMP Medica, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Evans, Clive W. The metastatic cell: Behaviour and biochemistry. London: Chapman and Hall, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Holding tight, letting go: Living with metastatic breast cancer. Cambridge: O'Reilly, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Shockney, Lillie. 100 questions & answers about advanced and metastatic breast cancer. 2nd ed. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

TxNxM1: The anatomy and clinics of metastatic cancer. Boston: Kluwer Academic Publishers, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Scheel, Camille. Camp chemo: Postcards home from metastatic breast cancer. Edina, MN: Beaver's Pond Press, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Hosseini, Hedayatollah. Molecular mechanism of early metastatic breast cancer dissemination. Regensburg: Universitätsbibliothek Regensburg, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Peter, Thomas. Metastatic potential of human colorectal cancer cell lines. Austin: R.G. Landes Co., 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Piñeiro, Roberto, ed. Circulating Tumor Cells in Breast Cancer Metastatic Disease. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-35805-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Herfarth, Christian, Peter Schlag, and Peter Hohenberger, eds. Therapeutic Strategies in Primary and Metastatic Liver Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-82635-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Sara, Booth, and Bruera Eduardo, eds. Palliative care consultations in primary and metastatic brain tumours. Oxford: Oxford University Press, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Orthopaedic management of metastatic bone disease. St. Louis: Mosby, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Shockney, Lillie. 100 Q&A about advanced and metastatic breast cancer. Sudbury, Mass: Jones and Bartlett, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Mayer, Musa. Advanced breast cancer: A guide to living with metastatic disease. 2nd ed. Beijing: O'Reilly, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Shockney, Lillie. 100 questions & answers about advanced and metastatic breast cancer. 2nd ed. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Balaji, K. C., ed. Managing Metastatic Prostate Cancer In Your Urological Oncology Practice. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-31341-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Shockney, Lillie. 100 questions & answers about advanced and metastatic breast cancer. 2nd ed. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

illustrator, Smith Christina G., ed. The cancer that wouldn't go away: A story for kids about metastatic cancer. [United States]: [ICGtesting], 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Miele, Carol A. Metastatic madness: How I coped with a stage 4 cancer diagnosis. Bloomington, Indiana]: Xlibris, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Jena, Vinod. Metastatic Cancer Chemistry. Lulu Press, Inc., 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Sherbet, R. Metastatic Spread of Cancer. Palgrave Macmillan, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

McDonald, Elizabeth S., Azadeh Elmi, and David A. Mankoff. Breast Cancer Metastatic Imaging. Edited by Christoph I. Lee, Constance D. Lehman, and Lawrence W. Bassett. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190270261.003.0010.

Full text

Abstract:

This chapter reviews appropriate indications for advanced imaging, such as PET/CT, in the evaluation of breast cancer. An informed imaging approach is based on primary tumor size and pathological characteristics, as well as patient symptoms that may indicate a higher likelihood of metastatic disease. When evaluation for metastatic disease is indicated, survey imaging with CT, bone scintigraphy, abdominal MRI, brain MRI, and/or PET/CT can be used to establish disease burden, and to identify a biopsy target for pathological confirmation. We emphasize the evolving role of FDG PET/CT in this chapter, including basic principles of PET imaging, followed by a short section on image interpretation. Finally, the concept of using imaging as a response biomarker is introduced.

APA, Harvard, Vancouver, ISO, and other styles

31

Health, Jumo. Understanding Metastatic Breast Cancer. Jumo Health, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Mahon, Suzanne Marie Dubuque. PSYCHOSOCIAL ADJUSTMENT TO RECURRENT CANCER (METASTATIC CANCER, CANCER). 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Wong, Han Hsi, Basma Greef, and Tim Eisen. Treatment of metastatic renal cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0089.

Full text

Abstract:

Metastatic renal cancer is resistant to standard chemotherapy. Although some patients with indolent disease can be initially managed with observation, the majority of patients will require aggressive treatment soon after diagnosis. Options include cytoreductive nephrectomy, resection of a solitary metastasis in highly selected cases, or systemic therapy options. The TKIs sunitinib and pazopanib are currently the first-line treatments of choice. Whilst axitinib and cabozantinib have important roles in the second line the PD-1 checkpoint inhibitor, nivolumab, is now established as standard second line therapy. Inhibitors of the mammalian target of rapamycin (mTOR) pathway, everolimus and temsirolimus, interleukin-2 as well as the anti-angiogenic antibody bevacizumab have also been shown to be effective. The treatment paradigm of metastatic renal cancer is constantly changing as evidence from clinical trials continues to emerge. With the development of agents addressing novel targets such as T-cell regulation, the future certainly looks brighter for patients diagnosed with this disease.

APA, Harvard, Vancouver, ISO, and other styles

34

Johnston, Stephen, and Charles Swanton. Handbook of Metastatic Breast Cancer. Informa Healthcare, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Swanton, Charles, and Stephen R. D. Johnston. Handbook of Metastatic Breast Cancer. Taylor & Francis Group, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

A, Rosenberg Steven, ed. Surgical treatment of metastatic cancer. Philadelphia: Lippincott, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Clarke, Noel W. Metastatic disease in prostate cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0068.

Full text

Abstract:

Metastases are the predominant cause of morbidity and death from prostate cancer (CaP). The tendency for cells to migrate from the primary site, enter the vascular/lymphatic circulation, and implant/grow at secondary sites is the principal discriminator of aggressive form indolent disease. But this process is poorly understood. Cells enter the circulation in increasing number as the disease progresses, impinging on endothelial surfaces, particularly in red bone marrow where they bind and transmigrate, forming early cell colonies. This requires chemo-attractants and nutrients enabling cellular survival. Established metastases thrive independently, disrupting local tissue, as characterized by progressive replacement of red bone marrow and disruption of skeletal architecture. Bone disruption includes massive overstimulation of both osteoblasts and osteoclasts, inducing synchronous over-production of abnormal bone and gross osteolysis.

APA, Harvard, Vancouver, ISO, and other styles

38

Calabrò, Fabio, and Cora N. Sternberg. Treatment of metastatic bladder cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0079.

Full text

Abstract:

Although bladder cancer is considered a chemosensitive malignancy, the prognosis of patients with metastatic disease is poor, with a median survival of approximately 12–14 months in good prognosis patients and with cure in only a minority. The addition of new drugs to the standard cisplatin-based regimens has not improved these outcomes. In this chapter, we highlight the role of chemotherapy and the impact of the new targeted agents in the treatment of metastatic bladder carcinoma. A better understanding of the underlying biology and the molecular patterns of urothelial bladder cancer has led to clinical investigation of several therapeutic targets. To date, these agents have yet to demonstrate an improvement in overall survival. Urothelial cancer is extremely sensitive to checkpoint inhibition with both anti PD-1 and anti PDL1 antibodies. The future seems brighter with the advent of these new therapies.

APA, Harvard, Vancouver, ISO, and other styles

39

The Metastatic Spread of Cancer. Palgrave Macmillan, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Swanton, Charles, and Stephen R. D. Johnston, eds. Handbook of Metastatic Breast Cancer. CRC Press, 2011. http://dx.doi.org/10.3109/9781841848129.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Swanton, Charles, and Stephen Johnston. Handbook of Metastatic Breast Cancer. Edited by Charles Swanton and Stephen R. D. Johnston. CRC Press, 2006. http://dx.doi.org/10.3109/9780203696910.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Swanton, Charles, and Stephen R. D. Johnston. Handbook of Metastatic Breast Cancer. Taylor & Francis Group, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Swanton, Charles, and Stephen Johnston. Handbook of Metastatic Breast Cancer. Taylor & Francis Group, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Swanton, Charles, and Stephen R. D. Johnston. Handbook of Metastatic Breast Cancer. Taylor & Francis Group, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Wick, Mark R. Metastatic Carcinomas of Unknown Origin. Springer Publishing Company, Incorporated, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

H, Schroeder Fritz, and Richards B. A, eds. Therapeutic principles in metastatic prostatic cancer. New York: A.R. Liss, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Coleman, Robert, R. M. D. Berenson James, and Gregory A. Mundy. The Management of Metastatic Bone Cancer. Not Avail, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

1949-, Enghofer E., Henderson I. Craig, and Kaufmann M. 1946-, eds. Therapeutic management of metastatic breast cancer. Berlin: Walter de Gruyter, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Allsop, Matthew J., and Michael Bennett. Undertreatment of pain with metastatic cancer. Edited by Paul Farquhar-Smith, Pierre Beaulieu, and Sian Jagger. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198834359.003.0051.

Full text

Abstract:

The landmark paper discussed in this chapter is ‘Pain and its treatment in outpatients with metastatic cancer’, published by Cleeland et al. in 1994. Cleeland and colleagues provide one of the first epidemiological studies outlining the prevalence of cancer pain in outpatients with metastatic cancer. The study drew attention to the undertreatment of pain and identified predictors of poor pain management, such as discrepancies between patient and health professional judgements regarding the degree of pain-induced interference. Issues highlighted by Cleeland and colleagues persist, including high prevalence of pain reported in patients with metastatic cancer, a lack of clarity on good practice guidelines for assessing pain in patients with cancer, and substandard quality of palliative and end-of-life services by minority ethnic groups. Pain management in outpatients with cancer remains a complex issue, but innovative strategies are emerging to support the role of the health professional and encouraging self-management in patients.

APA, Harvard, Vancouver, ISO, and other styles

50

Kaufmann, M., I. C. Henderson, and E. Enghofer, eds. Therapeutic Management of Metastatic Breast Cancer. De Gruyter, 1989. http://dx.doi.org/10.1515/9783110888942.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!